AlphaYouXENE: Kelly Thomas Patrick discloses a purchase
By AlphaYouPublished Form 4
Kelly Thomas Patrick
Reporting filer
Kelly Thomas Patrick reported Purchase in Xenon Pharmaceuticals Inc.: 15000 units of Common Shares, dated 2026-09-30. The full Form 4 contains 1 transaction entry.
- Disclosed
- Oct 1, 2026
Reported details
1 entry| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Shares | Kelly Thomas Patrick | 2026-09-30 | P | Purchase | 15000 | 37.316 | 15,000 | 1 day | Filed terms
|
Common Shares
- Owner
- Kelly Thomas Patrick
- Date
- 2026-09-30
- Code
- P
- Action
- Purchase
- Quantity
- 15000
- Price
- 37.316
- Following holdings
- 15,000
- Reporting delay
- 1 day
- Filed terms and references
Filed terms
- security Title: Common Shares
- transaction Date: 2026-09-30
- transaction Form Type: 4
- transaction Code: P
- equity Swap Involved: false
- transaction Shares: 15000
- transaction Price Per Share: 37.316
- transaction Acquired Disposed Code: A
- shares Owned Following Transaction: 15000
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Kelly Thomas Patrick: Chief Financial Officer.
Original sources
Prepared automatically from public filing data. Report a correction.